V. Johnston

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)

Grace Kong, Matthew Thompson, Marnie Collins et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 91 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Carboplatin dosing based on measurement of renal function — experience at the Peter MacCallum Cancer Institute

Michael Millward, Lorraine K. Webster, Guy C. Toner et al. · Australian and New Zealand Journal of Medicine · 1996 · 58 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

High-Administered Activity In-111 Octreotide Therapy with Concomitant Radiosensitizing 5FU Chemotherapy for Treatment of Neuroendocrine Tumors: Preliminary Experience

Grace Kong, V. Johnston, Shakher Ramdave et al. · Cancer Biotherapy and Radiopharmaceuticals · 2009 · 47 citations

Medicine, Oncology, Pharmacology +17

⁶⁸Ga-EDTA PET/CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification: Comparison to Conventional ⁵¹Cr-EDTA

Michael S. Hofman, David Binns, V. Johnston et al. · Journal of Nuclear Medicine · 2015 · 43 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Contrast-enhanced dynamic magnetic resonance imaging of finger joints in osteoarthritis and rheumatoid arthritis: an analysis based on pharmacokinetic modeling

Eva Kirkhus, Atle Bjørnerud, J. Thöen et al. · Acta Radiologica · 2006 · 34 citations

Medicine, Pharmacokinetics, Radiology +17